Sorry, this entry is only available in Ukrainian.
Вас может заинтересовать:
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
WEB only
Sanofi, a global pharmaceutical company, has reached a definitive agreement to acquire Qunol, a well-established brand in the health and wellness industry based in the US. The acquisition is aimed…